Scinai Immunotherapeutics Ltd. (SCNI)
NASDAQ: SCNI · Real-Time Price · USD
0.630
+0.046 (7.83%)
Apr 29, 2026, 1:02 PM EDT - Market open
Scinai Immunotherapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -8.31 | 4.8 | -6.5 | -5.8 | -8.21 | |
| Depreciation & Amortization | 1.42 | 1.65 | 0.51 | 0.56 | 0.47 | |
| Asset Writedown & Restructuring Costs | - | - | - | 0.21 | - | |
| Stock-Based Compensation | 0.3 | 0.68 | 1.14 | 1.6 | 2.76 | |
| Other Operating Activities | 0.39 | -13.57 | -3.74 | -4.11 | -3.15 | |
| Change in Accounts Receivable | 0.01 | -0.08 | - | - | 0.06 | |
| Change in Accounts Payable | 0.03 | -0.16 | -0.15 | -0.18 | 0 | |
| Change in Other Net Operating Assets | 0.12 | 0.35 | -0.65 | 0.45 | 0.64 | |
| Operating Cash Flow | -6.03 | -6.34 | -9.38 | -7.27 | -7.43 | |
| Capital Expenditures | -0.02 | -0.01 | -0.64 | -0.84 | -0.14 | |
| Investing Cash Flow | -0.02 | -0.01 | -0.64 | -0.84 | -0.14 | |
| Issuance of Common Stock | 5.77 | 1.44 | 1.09 | 6.78 | 21.43 | |
| Other Financing Activities | - | 2 | - | - | - | |
| Financing Cash Flow | 5.77 | 3.44 | 1.09 | 6.78 | 21.43 | |
| Foreign Exchange Rate Adjustments | 0 | -0.01 | -0.27 | -1.98 | 0.58 | |
| Net Cash Flow | -0.28 | -2.92 | -9.21 | -3.3 | 14.44 | |
| Free Cash Flow | -6.06 | -6.35 | -10.02 | -8.1 | -7.57 | |
| Free Cash Flow Margin | -461.86% | -964.59% | - | - | - | |
| Free Cash Flow Per Share | -2.59 | -7.87 | -25.65 | -42.97 | -53.60 | |
| Cash Interest Paid | - | 0.14 | 0.83 | 0.92 | - | |
| Levered Free Cash Flow | -3.33 | -3.82 | -8.28 | -5.52 | -2.71 | |
| Unlevered Free Cash Flow | -3.1 | -2.93 | -5.9 | -5.52 | -2.71 | |
| Change in Working Capital | 0.16 | 0.11 | -0.8 | 0.27 | 0.7 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.